Home
Storia in 1 fonti
Q&A: Understanding the relationship between lymphoma, eczema and dupilumab
The dermatology community has long debated whether dupilumab treatment for atopic dermatitis is associated with the development of cutaneous T-cell lymphoma — a concern that becomes more urgent when children are involved. In 2024, a retrospective cohort study suggested that dupilumab (Dupixent; Sanofi, Regeneron) was associated with an increased risk for cutaneous T-cell lymphoma in
Raccontata da
healio.com
Timeline cronologica
- ·
Q&A: Understanding the relationship between lymphoma, eczema and dupilumab
The dermatology community has long debated whether dupilumab treatment for atopic dermatitis is associated with the development of cutaneous T-cell lymphoma — a concern that…
- ·
Dupilumab shows benefits in infants with EoE not meeting approval thresholds
Among infants with eosinophilic esophagitis aged younger than 1 year or weighing less than 15 kg, esophageal eosinophilia and growth improved after starting dupilumab, according…